Since the beginning of 2021, the biomedical team led by Zhao Yongfa, a partner of New Value Capital, has emphasized the high pressure on the primary market due to the potential risks of the future bubble bursting in the secondary market, and urged the investment cycle to move forward. The seed round Shenzhen Alpha Molecular Technology Co., Ltd., which Zhao Yongfa personally led the investment, is the first seed round project invested by New Henglida Capital. Over the past year, several products of Alpha Molecule have been recognized by Shanghai Pharmaceutical, reached cooperation agreements, and generated revenue. On this basis, Alpha Molecule recently won the A round led by Shanghai Biomedical Industry Equity Investment Fund Partnership (Limited Partnership), marking that Alpha Molecule's new drug original research and product prospects have been recognized by the industry, which is gratifying! New Henglida Capital followed the A round after the seed round and accompanied the Alpha Academician team to success.

Headquartered in Shenzhen, Shenzhen AlphaMol focuses on new drug innovation using biocomputing, artificial intelligence and original biotechnology. The core members are PhDs from the R&D departments of large Swiss pharmaceutical companies and professors from Swiss international universities. In 2022, the founding partners of the team, Academician Horst Vogel and Dr. Yuan Shuguang, were both selected into the list of top 2% scientists in the world.

The team has rich experience in promoting the research and development of "first-in-class" clinical new drugs, and has also invented a series of world-first biotechnologies, including: the world's first optical biochip to test G protein-coupled receptor protein (GPCR, the most important drug development target, nearly 40% of marketed drugs are developed for GPCR), the world's first biochip to test cell electrophysiology, the world's first biochip to track single-molecule cells, etc. At the end of 2021, the team participated in the global GPCR-DOCK computer predictive modeling competition, defeated Google AlphaFold2 in relevant target predictions, and ranked second, third and fifth in the world.